Filing Details

Accession Number:
0001411686-10-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-19 12:00:00
Reporting Period:
2010-02-16
Filing Date:
2010-02-19
Accepted Time:
2010-02-19 16:05:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017259 Nmt Medical Inc NMTI Surgical & Medical Instruments & Apparatus (3841) 954090463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1137521 Glenhill Advisors Llc 156 West 56Th Street
17Th Floor
New York NY 10019
No No Yes No
1137522 Glenhill Capital Management Llc 156 West 56Th Street
17Th Floor
New York NY 10019
No No Yes No
1159120 J Glenn Krevlin 156 West 56Th Street
17Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-16 761,938 $2.15 2,609,358 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant (Right to Buy) Acquisiton 2010-02-16 761,938 $2.15 609,550 $2.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
761,938 2010-08-17 2015-02-16 No 4 P Indirect
Footnotes
  1. Reporting person, Glenn J. Krevlin, is the managing member of Glenhill Advisors, LLC, a limited liability company that is managing member of Glenhill Capital Management LLC, which has investment control and owns a minority interest in various private investment funds, including Glenhill Capital LP, Glenhill Capital Overseas Master Fund, LP and Glenhill Concentrated Long Master Fund LLC, which collectively own the reported securities. The reporting persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Of the securities reported in this Form 4, Glenhill Capital LP purchased 345,528 securities, Glenhill Capital Overseas Master Fund, LP purchased 306,410 securities, and Glenhill Concentrated Long Master Fund L.L.C. purchased 110,000 securities. Of the 2,609,358 securities reported in this Form 4, reporting person Glenn J. Krevlin directly beneficially owns 69,820 of the issuer's securities.
  2. In addition, the warrants shall not be exercisable until the closing price per share of the Common Stock of the issuer is equal to or greater than $2.90 per share for five consecutive trading days following such date.